Trials / Completed
CompletedNCT02466997
Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC
Efficacy of Tacrolimus Ointment 0.1% Versus Placebo in Adults With Facial Non-segmental Vitiligo: a Randomized Double-blind Controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University Hospital, Bordeaux · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicentric French parallel double-blind randomized versus placebo study
Detailed description
Multicentric French parallel double-blind randomized versus placebo study, with duration of treatment of 6 months, and a post-treatment follow-up period of 6 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus | tacrolimus 0.1% ointment applied twice a day for the experimental group during 24 weeks placebo ointment applied twice a day for the control group during 24 weeks |
| DRUG | Placebo |
Timeline
- Start date
- 2016-02-23
- Primary completion
- 2018-09-30
- Completion
- 2018-09-30
- First posted
- 2015-06-09
- Last updated
- 2021-04-19
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02466997. Inclusion in this directory is not an endorsement.